» Articles » PMID: 39254774

Association of Food Group with the Changes in Sarcopenia Parameters over 1 year in Older Outpatients in a Frailty Clinic

Overview
Journal Eur Geriatr Med
Specialty Geriatrics
Date 2024 Sep 10
PMID 39254774
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: This study investigated the relationship between food group and the changes in sarcopenia parameters in 1 year among older outpatients.

Methods: A prospective cohort study conducted between July 2017 and April 2021 included patients aged ≥ 65 years attending a frailty clinic. Food group consumption adjusted for energy and body weight was conducted using a self-administered dietary history questionnaire. Ordinal logistic regression analysis was used to examine the association between tertiles of adjusted food group consumption and outcomes, including a handgrip strength decline, prolonged five-time chair stand test (5CST), decreased skeletal muscle mass index (SMI), and decreased gait speed in 1 year. Covariates included age, sex, height, energy intake, number of comorbidities, and the Baecke activity score.

Results: In the analysis of 165 participants (mean age 77.6 ± 6.1 years, 107 women), individuals with higher consumption of sugar and sweeteners had a significantly increased risk for handgrip strength decline (OR 2.46, 95% CI 1.15-5.23, P = 0.020) and prolonged 5CST (OR 3.14, 95% CI 1.38-7.13, P = 0.006). Higher consumption of beverages increased the risk of handgrip strength decline (OR 2.30, 95% CI 1.11-4.76, P = 0.025). Conversely, higher legume consumption decreased the risk of SMI reduction (OR 0.35, 95%CI 0.16-0.76, P = 0.008), higher fruit consumption reduced the risk of prolonged 5CST time (OR 0.29, 95% CI 0.13-0.67, P = 0.004), and higher green yellow vegetables consumption decreased the risk of reduced gait speed (OR 0.38, 95% CI 0.17-0.84, P = 0.017).

Conclusion: Sugar, sweeteners, and beverages are associated with worsened sarcopenia parameters, whereas consumption of legumes, vegetables, and fruits is associated with a lower risk.

References
1.
Chen L, Woo J, Assantachai P, Auyeung T, Chou M, Iijima K . Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020; 21(3):300-307.e2. DOI: 10.1016/j.jamda.2019.12.012. View

2.
Cruz-Jentoft A, Sayer A . Sarcopenia. Lancet. 2019; 393(10191):2636-2646. DOI: 10.1016/S0140-6736(19)31138-9. View

3.
Beaudart C, Zaaria M, Pasleau F, Reginster J, Bruyere O . Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis. PLoS One. 2017; 12(1):e0169548. PMC: 5240970. DOI: 10.1371/journal.pone.0169548. View

4.
Robinson S, Reginster J, Rizzoli R, Shaw S, Kanis J, Bautmans I . Does nutrition play a role in the prevention and management of sarcopenia?. Clin Nutr. 2017; 37(4):1121-1132. PMC: 5796643. DOI: 10.1016/j.clnu.2017.08.016. View

5.
Robinson S, Granic A, Cruz-Jentoft A, Sayer A . The role of nutrition in the prevention of sarcopenia. Am J Clin Nutr. 2023; 118(5):852-864. PMC: 10636259. DOI: 10.1016/j.ajcnut.2023.08.015. View